Angiopent Retard

Medicinal product

(Invented) name

Angiopent Retard

Active substance (s)

Pentoksifilinas

Strength

400 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C04AD03, Pentoxifylline

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2023-12-12

Date of renewal

Documents

2044_Angiopent Retard 400 PZ_2023 12 12.docx

2044_Angiopent Retard 400 PL_2023 12 12.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Pentoksifilinas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112294	98409	1098409	lizdinė plokštelė	N40		Receptinis	LT/L/23/2044/001	Netiekiama	2025-07-08	2025-08-17	No	-	-	Download

Stadijos

Data	Stadija
2023-12-12	Registruotas